CompoAtlas

Harrington's No 5 - Pain & Arthritis

Testo originale in francese.

Prodotto naturale per la salute autorizzato in Canada

Se questo prodotto fosse venduto in Francia

Si calcola una quantità giornaliera solo per una posologia orale esplicita per adulti, espressa al giorno e in un’unità solida corrispondente alla forma del prodotto. Unità ambigue, liquidi, polveri e dosi pediatriche non vengono estrapolati. Una quantità non calcolata non viene confrontata con i limiti di dose. Questa analisi non costituisce un’autorizzazione alla vendita in Francia né una valutazione di sicurezza o efficacia.

Composizione

Ingrediente medicinale e fontePer unità posologica, secondo la fonteMassimo giornaliero, adulto
(1E,6E)-1,7-Bis(4-hydroxy-3-méthoxyphényl)-1,6-heptadiène-3,5-dione

Fonte : Curcuma longa - rhizome

114 milligrammeNon calcolata
Salix alba

Fonte : Écorce (branche)

Estratto : Matériel brut sec

Rapporto di estrazione : 15:1

Equivalente di pianta secca : 1.800 milligramme

120 milligrammeNon calcolata
Harpagophytum procumbens

Fonte : Racine

Estratto : Matériel brut sec

Rapporto di estrazione : 15:1

Equivalente di pianta secca : 1.800 milligramme

Potenza : 5 % Harpagoside

120 milligrammeNon calcolata
Boswellia serrata

Fonte : écorce de tige oléorésine

Estratto : Matériel brut sec

Rapporto di estrazione : 20:1

Equivalente di pianta secca : 2.400 milligramme

120 milligrammeNon calcolata
Corydalis yanhusuo

Fonte : Tubercule

Estratto : Matériel brut sec

Rapporto di estrazione : 7,5:1

Equivalente di pianta secca : 900 milligramme

120 milligrammeNon calcolata

Ingredienti non medicinali

Hypromellose

Dosi raccomandate in Canada

PopolazioneEtàQuantità per assunzioneFrequenza
AdultesNon précisée1 Capsule3 Tous les jours

Usi autorizzati in Canada

Traditionally used in Herbal Medicine for the relief of minor joint pain (due to osteoarthritis). Used in Herbal Medicine to help relieve joint pain associated with osteoarthritis. Used in Herbal Medicine for short-term relief of low back pain.

Testo originale in francese.

Un uso autorizzato in Canada non è un’indicazione sulla salute autorizzata nell’Unione europea. Consulti il registro delle indicazioni sulla salute.

Avvertenze in Canada

Contre-indications : If you are pregnant or breastfeeding, do not use this product. If you are allergic to acetylsalicylic acid (ASA) or other salicylates, do not use this product. Do not use in all cases or early menstruation, deficiency with continuous menstrual bleeding and postpartum deficiency.

Testo originale in francese.

Précautions et mises en garde : If you have asthma or peptic ulcer disease, consult a health care practitioner prior to use. If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. If you are taking prescription medications, consult a health care practitioner prior to use. Do not exceed recommended dose; drowsiness, dizziness and abdominal distention may occur. If you are taking antiplatelet medication or blood thinners, consult a health care practitioner prior to use. If you have gallstones or a bile duct obstruction, consult a health care practitioner prior to use. If you have stomach ulcers or excess stomach acid, consult a health care practitioner prior to use. If you are taking anticoagulants or products containing acetylsalicylic acid (ASA) or other salicylates, consult a health care practitioner prior to use.

Testo originale in francese.

Effets indésirables connus : Do not take if you are allergic to the Papaveraceae family. Discontinue use and consult your health care practitioner if you experience fever, erythema and pruritus accompanied by nausea, dizziness, shortness of breath, and numbness of the lips and extremities. Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use. If you experience gastrointestinal symptoms such as nausea, vomiting, abdominal pain, dyspepsia, heartburn or diarrhea, discontinue use and consult a health care practitioner.

Testo originale in francese.

Scheda del prodotto

Altri nomi
Harrington's No 5 - For Pain & Arthritis, Pain & Arthritis Formula
Titolare
The Harrington Method
NPN o DIN-HM
80075532
Stato
Licenza attiva
Data della licenza
9 febbraio 2017
Data di revisione
Non indicata
Forma
Capsule
Via di somministrazione
Orale
Tipo di domanda
Non traditionnelle

Fonte

Scheda ufficiale Health Canada, licenza 80075532

Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze, consultato il 27 ottobre 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Testo originale in inglese.

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Testo originale in francese.

La formula venduta in Europa con lo stesso nome può essere diversa. Queste informazioni non sostituiscono il parere di un medico o farmacista.

Avvertenze ufficiali (Health Canada)

Health Canada pubblica avvertenze su questi ingredienti:

  • Salix alba
    Leggere l'avvertenza, quando si applica e gli studi citati

    Testo originale ufficiale in inglese.

    WILLOW BARK

    Via di somministrazione: Oral

    Precauzioni e avvertenze

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have asthma or peptic ulcer disease (EMA 2017).

    Fonti citate da Health Canada (1)
    • EMA 2017 European Medicines Agency. European Union herbal monograph on Salix [various species including S. purpurea L., S. daphnoides Vill., S. fragilis L.], cortex. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 31 January 2017. [Accessed 2023 October 14].Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-salix-various-species-including-s-purpurea-l-s-daphnoides-vill_en.pdf

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or products containing salicylates (e.g., acetylsalicylic acid or non-steroidal anti-inflammatory drugs) (EMA 2017).

    Fonti citate da Health Canada (1)
    • EMA 2017 European Medicines Agency. European Union herbal monograph on Salix [various species including S. purpurea L., S. daphnoides Vill., S. fragilis L.], cortex. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 31 January 2017. [Accessed 2023 October 14].Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-salix-various-species-including-s-purpurea-l-s-daphnoides-vill_en.pdf

    Controindicazioni

    Do not use if you are pregnant or breastfeeding (EMA 2017; Brinker 2010; Wichtl 2004; ESCOP 2003; Barnes et al. 2002; Blumenthal et al. 2000).

    Fonti citate da Health Canada (6)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines: A Guide for Healthcare Professionals. 2nd edition. London (GB): The Pharmaceutical Press; 2002.
    • Blumenthal M, Goldberg A, Brinckmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 3rd edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2017 European Medicines Agency. European Union herbal monograph on Salix [various species including S. purpurea L., S. daphnoides Vill., S. fragilis L.], cortex. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 31 January 2017. [Accessed 2023 October 14].Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-salix-various-species-including-s-purpurea-l-s-daphnoides-vill_en.pdf
    • ESCOP 2003: E/S/C/O/P Monographs: The Scientific Foundation for Herbal Medicinal Products. 2nd edition. Exeter (GB): ESCOP, the European Scientific Cooperative on Phytotherapy in collaboration with Georg Thieme Verlag and Thieme; 2003.
    • Wichtl M, editor. Herbal Drugs and Phytopharmaceuticals: A Handbook for Practice on a Scientific Basis. 3rd edition. Stuttgart (DE): Medpharm Scientific Publishers; 2004.

    Do not use if you are allergic to salicylates (EMA 2017; Brinker 2010; Wichtl 2004, ESCOP 2003; Barnes et al. 2002; Blumenthal et al. 2000).

    Fonti citate da Health Canada (6)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines: A Guide for Healthcare Professionals. 2nd edition. London (GB): The Pharmaceutical Press; 2002.
    • Blumenthal M, Goldberg A, Brinckmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 3rd edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2017 European Medicines Agency. European Union herbal monograph on Salix [various species including S. purpurea L., S. daphnoides Vill., S. fragilis L.], cortex. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 31 January 2017. [Accessed 2023 October 14].Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-salix-various-species-including-s-purpurea-l-s-daphnoides-vill_en.pdf
    • ESCOP 2003: E/S/C/O/P Monographs: The Scientific Foundation for Herbal Medicinal Products. 2nd edition. Exeter (GB): ESCOP, the European Scientific Cooperative on Phytotherapy in collaboration with Georg Thieme Verlag and Thieme; 2003.
    • Wichtl M, editor. Herbal Drugs and Phytopharmaceuticals: A Handbook for Practice on a Scientific Basis. 3rd edition. Stuttgart (DE): Medpharm Scientific Publishers; 2004.

    Reazioni avverse note

    When using this product you may experience gastrointestinal discomfort/disturbances (EMA 2017; Brinker 2010; Wichtl 2004; ESCOP 2003; Barnes et al. 2002; Blumenthal et al. 2000)

    Fonti citate da Health Canada (6)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines: A Guide for Healthcare Professionals. 2nd edition. London (GB): The Pharmaceutical Press; 2002.
    • Blumenthal M, Goldberg A, Brinckmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 3rd edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2017 European Medicines Agency. European Union herbal monograph on Salix [various species including S. purpurea L., S. daphnoides Vill., S. fragilis L.], cortex. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 31 January 2017. [Accessed 2023 October 14].Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-salix-various-species-including-s-purpurea-l-s-daphnoides-vill_en.pdf
    • ESCOP 2003: E/S/C/O/P Monographs: The Scientific Foundation for Herbal Medicinal Products. 2nd edition. Exeter (GB): ESCOP, the European Scientific Cooperative on Phytotherapy in collaboration with Georg Thieme Verlag and Thieme; 2003.
    • Wichtl M, editor. Herbal Drugs and Phytopharmaceuticals: A Handbook for Practice on a Scientific Basis. 3rd edition. Stuttgart (DE): Medpharm Scientific Publishers; 2004.

    Monografia di Health Canada del 28 marzo 2024

  • Harpagophytum procumbens
    Leggere l'avvertenza, quando si applica e gli studi citati

    Testo originale ufficiale in inglese.

    DEVIL'S CLAW - HARPAGOPHYTUM

    Via di somministrazione: Oral

    Precauzioni e avvertenze

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Monografia di Health Canada del 27 marzo 2026

Riguardano l'ingrediente, non questo prodotto né la sua dose. Non sostituiscono il parere medico.

La data della prova di questo elenco di ingredienti è sconosciuta.

Il prodotto è cambiato? Fotografi la confezione.

Un'informazione inesatta o più recente su questo prodotto, che lei sia lettore o marca? Scriva a contact@compoatlas.com: ogni correzione è pubblicata nel registro delle correzioni.

Invio per analizzare, Maiusc+Invio per una nuova riga